Feature extraction using molecular planes for fuzzy relational clustering of a flexible dopamine reuptake inhibitor

Journal of Chemical Information and Modeling

Volumn 47, Issue 6, 2007, Pages 2216-2227

  Banerjee, Amit ^a,c   Misra, Milind ^a,d   Pai, Deepa ^a,e   Shih, Liang Yu ^a,f   Woodley, Rohan ^a   Lu, Xiang Jun ^b,g   Srinivasan, A R ^b   Olson, Wilma K ^b   Davé, Rajesh N ^a,h   Venanzi, Carol A ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c University of Nevada   (United States)

^d SANDIA NATIONAL LABORATORIES   (United States)

^e Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^f AMGEN INC   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

^h NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERING ALGORITHMS; CONFORMATIONS; FEATURE EXTRACTION; MOLECULAR ORIENTATION; NUCLEIC ACIDS;

FUZZY RELATIONAL CLUSTERING; MOLECULAR FRAGMENTS; PHARMACOPHORE ELEMENTS; SIX RIGID-BODY PARAMETERS;

MOLECULAR DYNAMICS;

DNA; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; FUZZY LOGIC; GENETICS; METABOLISM; STRUCTURE ACTIVITY RELATION;

DNA; DOPAMINE; DOPAMINE ANTAGONISTS; FUZZY LOGIC; MODELS, MOLECULAR; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 37249081116     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci7001632     Document Type: Article

References (49)

1. Nicklaus, M. C.; Wang, S.; Driscoll, J.; Milne, G. W. A. Conformational Changes of Small Molecules Binding to Proteins. Bioorg. Med. Chem. 1995, 5, 411-428.
2. Veith, M.; Hirst, J. D.; Brooks, C. L., III Do Active Site Conformations. of Small Ligands Correspond to Low Free-Energy Solution Structures? J. Comput.-Aided Mol. Des. 1998, 12, 563-572.
3. Debnath, A. K. Comparative Molecular Field Analysis (CoMFA) of a Series of Symmetrical Bis-Benzamide Cyclic Urea Derivatives as HIV-1 Protease Inhibitors. J. Chem. Inf. Comput. Sci. 1999, 38, 761-767.
4. Perola, E.; Charifson, P. S. Conformational Analysis of Drug-like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization Upon Binding. J. Med. Chem. 2004, 47, 2499-2510.
5. Guarnieri, F.; Weinstein, H. Conformational Memories and the Exploration of Biologically Relevant Peptide Conformations: An Illustration for the Gonadotropin-Releasing Hormone. J. Am. Chem. Soc. 1996, 118, 5580-5589.
6. Hopfinger, A. J.; Tokarski, J. S. Three-Dimensional Quantitative Structure-Activity Relationship Analysis. In Practical Application of Computer-Aided Drug Design; Charifson, P. S., Ed.; Marcel Dekker: New York, 1997; pp 105-164.
7. Barnett-Norris, J.; Guarnieri, F.; Hurst, D. P.; Reggio, P. H. Exploration of Biologically Relevant Conformations of Anandamide, 2-Arachinodylglycerol, and Their Analogues Using Conformational Memories. J. Med. Chem. 1998, 41, 4861-4872.
8. Barnett-Norris, J.; Hurst, D. P.; Lynch, D. L.; Guarnieri, F.; Makriyannis, A.; Reggio, P. H. Conformational Memories and the Endocannabinoid Binding Site at the Cannabinoid CB1 Receptor. J. Med. Chem. 2002, 45, 3649-3659.
9. Greenidge, P. A.; Merette, S. A. M.; Beck, R.; Dodson, G.; Goodwin, C. A.; Scully, M. F.; Spencer, J.; Weiser, J.; Deadman, J. J. Generation of Ligand Conformations in Continuum Solvent Consistent with Protein Active Site Topology: Application to Thrombin. J. Med. Chem. 2003, 46, 1293-1305.
10. Bernard, D.; Coop, A.; MacKerell, A. D., Jr. 2D Conformationally Sampled Pharmacophore: A Ligand-Based Pharmacophore to Differentiate δ Opioid Agonists from Antagonists. J. Am. Chem. Soc. 2003, 125, 3101-3107.
11. Bernard, D.; Coop, A.; MacKerell, A. D., Jr. Conformationally Sampled Pharmacophore for Peptide Delta Opiod Ligands. J. Am. Chem. Soc. 2005, 48, 7773-7780.
12. Cramer, R. D., III; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
13. Gilbert, K. M.; Venanzi, C. A. Hierarchical Clustering Analysis of Flexible GBR 12909 Dialkyl Piperazine and Piperidine Analogs. J. Comput.-Aided Mol. Des. 2006, 20, 209-225.
14. Misra, M.; Banerjee, A.; Davé, R. N.; Venanzi, C. A. Novel Feature Extraction Technique for Fuzzy Relational Clustering of a Flexible Dopamine Reuptake Inhibitor. J. Chem. Inf. Model. 2005, 45, 610-623.
15. Fiorentino, A.; Pandit, D.; Gilbert, K. M.; Misra, M.; Dios, R.; Venanzi, C. A. Singular Value Decomposition of Torsional Angles of Analogs of the Dopamine Reuptake Inhibitor GBR 12909. J. Comput. Chem. 2006, 27, 609-620.
16. Gilbert, K. M.; Boos, T. L.; Dersch, C. M.; Greiner, E.; Jacobson, A. E.; Lewis, D.; Matecka, D.; Prisinzano, T. E.; Zhang, Y.; Rothman, R. B.; Rice, K. C.; Venanzi, C. A. DAT/SERT Selectivity of Flexible GBR 12909 Analogs Modeled Using 3D-QSAR Methods. Bioorg. Med. Chem. 2007, 20, 1146-1159.
17. Prisinzano, T.; Rice, K. C.; Baumann, M. H.; Rothman, R. B. Development of Neurochemical Normalization ("Agonist Substitution") Therapeutics for Stimulant Abuse: Focus on the Dopamine Uptake Inhibitor, GBR12909. Curr. Med. Chem. CNS Agents 2004, 4, 47-59.
18. Glowa, J. R.; Fantegrossi, W. E.; Lewis, D. B.; Matecka, D.; Rice, K. C.; Rothman, R. B. Sustained Decrease in Cocaine-maintained Responding in Rhesus Monkeys with 1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-hydroxy-3- phenylpropyl)piperazinyl Decanoate, a Long-acting Ester Derivative of GBR 12909. J. Med. Chem. 1996, 39, 4689-4691.
19. Lu, X.-J.; Olson, W. K. 3DNA: A Software Package for the Analysis, Rebuilding and Visualization of Three-dimensional Nucleic Acid Structures. Nucleic Acids Res. 2003, 31, 5108-5121.
20. Matecka, D.; Rothman, R. B.; Radesca, L.; de Costa, B. R.; Dersch, C. M.; Partilla, J. S.; Pert, A.; Glowa, J. R.; Wojnicki, F. H. E.; Rice, K. C. Development of Novel, Potent, and Selective Dopamine Reuptake Inhibitors Through Alteration of the Piperazine Ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909). J. Med. Chem. 1996, 39, 4704-4716.
21. Matecka, D.; Lewis, D.; Rothman, R. B.; Dersch, C. M.; Wojnicki, F. H. E.; Glowa, J. R.; DeVries, A. C.; Pert, A.; Rice, K. C. Heteroatomic Analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl]-4-(3- phenylpropyl)piperazines(GBR 12935 and GBR 12909) as High-affinity Dopamine Reuptake Inhibitors. J. Med. Chem. 1997, 40, 705-716.
22. Lewis, D. B.; Matecka, D.; Zhang, Y.; Hsin, L. W.; Dersch, C. M.; Stafford, D.; Glowa, J. R.; Rothman, R. B.; Rice, K. C. Oxygenated Analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3- phenylpropyl)piperazines (GBR 12935 and GBR 12909) as Potential Extended-action Cocaine-abuse Therapeutic Agents. J. Med. Chem. 1999, 42, 5029-5042.
23. Hsin, L. W.; Dersch, C. M.; Baumann, M. H.; Stafford, D.; Glowa, J. R.; Rothman, R. B.; Jacobson, A. E.; Rice, K. C. Development of Long-acting Dopamine Transporter Ligands as Potential Cocaine-abuse Therapeutic Agents: Chiral Hydroxyl-containing Derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3- phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl) piperazine. J. Med. Chem. 2002, 45, 1321-1329.
24. Lewis, D.; Zhang, Y.; Prisinzano, T.; Dersch, C. M.; Rothman, R. B.; Jacobson, A. E.; Rice, K. C. Further Exploration of 1-{2-[bis-(4-fluorophenyl) methoxy]ethyl}piperazine (GBR 12909): Role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl Substituents on Affinity for the Dopamine and Serotonin Transporter. Bioorg. Med. Chem. Lett. 2003, 13, 1385-1389.
25. Dickerson, R. E.; Bansal, M.; Calladine, C. R.; Diekman, S.; Hunter, W. N.; Kennard, O.; von Kitzing, E.; Lavery, R.; Nelson, H. C. M.; Olson, W. K.; Saenger, W.; Shakked, Z.; Sklenar, H.; Soumpasis, D. M.; Tung, C.-S.; Wang, A. H.-J.; Zhurkin, V. B. Definitions and Nomenclature of Nucleic Acid Structure Parameters. J. Mol. Biol. 1998, 208, 787-791.
26. Werner, M. H.; Gronenborn, A. M.; Clore, G. M. Intercalation, DNA Kinking, and the Control of Transcription. Science 1996, 271, 778-784.
27. Lu, X.-J.; Olson, W. K. Resolving the Discrepancies Among Nucleic Acid Conformational Analyses. J. Mol. Biol. 1999, 285, 1563-1575.
28. Lu, X.-J.; Babcock, M. S.; Olson, W. K. Overview of Nucleic Acid Analysis Programs. J. Biomol. Struct. Dyn. 1999, 16, 833-843.
29. Olson, W. K.; Bansal, M.; Burley, S. K.; Dickerson, R. E.; Gerstein, M.; Harvey, S. C.; Heinemann, U.; Lu, X.-J.; Neidle, S.; Shakked, Z.; Sklenar, H.; Suzuki, M.; Tung, C.-S.; Westhof, E.; Wolberger, C.; Berman, H. M. A Standard Reference Frame for the Description of Nucleic Acid Base-pair Geometry. J. Mol. Biol. 2001, 313, 229-237.
30. Downs, G. M.; Barnard, J. M. Clustering Methods and Their Uses in Computational Chemistry. In Reviews in Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH: New York, 2002; Vol. 18, pp 1-40.
31. Shenkin, P. S.; McDonald, D. Q. Cluster Analysis of Molecular Conformations. J. Comput. Chem. 1994, 15, 899-916.
32. Chema, D.; Goldblum, A. The Nearest Neighbor Method - Finding Families of Conformations Within a Sample. J. Chem. Inf. Comput. Sci. 2003, 43, 208-217.
33. Feher, M.; Schmidt, J. M. Metric and Multidimensional Scaling: Efficient Tools for Clustering Molecular Conformations. J. Chem. Inf. Comput. Sci. 2001, 41, 346-353.
34. Feher, M.; Schmidt, J. M. Fuzzy Clustering as a Means of Selecting Representative Conformers and Molecular Alignments. J. Chem. Inf. Comput. Sci. 2003, 43, 810-818.
35. Davé, R. N.; Sen, S. Robust Fuzzy Clustering of Relational Data. IEEE Trans. Fuzzy Syst. 2002, 10, 713-727.
36. Bezdek, J. C. Pattern Recognition with Fuzzy Objective Function Algorithms; Plenum Press: New York, 1981.
37. Xie, X. L.; Beni, G. A Validity Measure for Fuzzy Clustering. IEEE Trans. Pattern Anal. Machine Intelligence 1991, 13, 841-847.
38. SYBYL 6.9; Tripos Inc.: 1699 South Hanley Rd., St. Louis, MO 63144, U.S.A.
39. Clark, M.; Cramer, R. D., III; van Opdenbosch, N. Validation of the General Purpose Tripos 5.2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
40. Horn, B. K. P. Closed-form Solution of Absolute Orientation Using Unit Quaternions. J. Opt. Soc. Am. 1987, 4, 629-642.
41. Wishart, D. k-Means Clustering with Outlier Deletion, for Data Mining with Mixed Variables and Missing Values. In Exploratory Data Analysis in Empirical Research; Schwaiger, M., Opitz, O., Eds.; Springer: Berlin, 2002; pp 216-226.
42. Pandit, D.; Roosma, W. A.; Misra, M.; Gilbert, K. M.; Skawinski, W. J.; Venanzi, C. A. Conformational Analysis of Piperazine and Piperidine Analogs of GBR 12909: Stochastic Approach to Evaluation of the Effect of Force Field and Solvent. J. Molec. Model. Submitted for publication.
43. Cannon, R. L.; Bezdek, J. C. Efficient Implementation of the Fuzzy c-Means Clustering Algorithms. IEEE Trans. Pattern Anal. Machine Intelligence 1986, 8, 248-255.
44. Chung, F. L.; Lee, T. Fuzzy Competitive Learning. Neural Net. 1994, 7, 539-551.
45. Bezdek, J. C.; Tsao, E.; Pal, N. R. Fuzzy Kohonen Clustering Networks. Pattern Recognit. 1994, 27, 757-764.
46. Davé, R. N. Validating Fuzzy Partitions Obtained Through c-Shells Clustering. Pattern Recognit. Lett. 1996, 17, 613-623.
47. Gunderson, R. Applications of Fuzzy ISODATA Algorithms to Star-tracker Printing Systems. Proceedings of the 7th Triennial World IFAC Congress; Helsinki, Finland, 1978; Pergamon: pp 1319-1323.
48. Fukuyama, Y.; Sugeno, M. A New Method of Choosing the Number of Clusters for the Fuzzy c-Means Method. Proceedings of the 5th Fuzzy Systems Symposium: Kobe, Japan, 1989; Japan Society for Fuzzy Sets and Systems: pp 247-250.
49. Pal, N. R.; Bezdek, J. C. On Cluster Validity for the Fuzzy c-Means Model. IEEE Trans. Fuzzy Syst. 1995, 3, 370-379.